PT  - JOURNAL ARTICLE
AU  - Georgiou, Harris V.
TI  - Social responsibility is the crucial factor in adopting early vaccination plans
AID  - 10.1101/2020.11.25.20238725
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.25.20238725
4099  - http://medrxiv.org/content/early/2020/11/29/2020.11.25.20238725.short
4100  - http://medrxiv.org/content/early/2020/11/29/2020.11.25.20238725.full
AB  - Early vaccination of the general population is a very crucial aspect in the successful mitigation of highly infectious diseases, as it is the case of the SARS-CoV-2 pandemic. The perception of possible side-effects from early batches of vaccines, presumably under-tested, is often a hindering factor for people not in high-risk categories to optin for early vaccination. In this work, early vaccination is formulated under a game-theoretic view with preference ranking and expectation maximization, in order to explore the constraints and conditions under which individuals are keen to opt-in for getting vaccinated. Although simple preference ranking leads to purely non-cooperative / non-altruistic Nash equilibrium, stable cooperative strategies can emerge under simple constraints on the payoffs, specifically the individual cost from possible side-effects versus the collective gain for the community (‘herd’) when endorsing vaccination by default.Significance StatementIf the collective gain from community-scale vaccination is deemed even marginally greater than each individual’s cost of possible side-effects, then the best strategy is to ‘cooperate’, i.e., every individual to opt-in for getting vaccinated.This condition is independent from the probabilities of getting infected, with or without vaccination, and it is sufficient to lead to a stable cooperative Nash equilibrium.In any lethal infectious disease like SARS-CoV-2 and less-than-lethal possible side-effects from the vaccine, for anyone that is susceptible plus one more in his/her own close environment, vaccination is the optimal strategy for all.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding must be reported for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethics oversight is required for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo datasets were used in this study.